KR840008153A - (1h-테트라졸-5-일)-2(1h)-퀴놀리논, 나프티리디논 및 그의 제조방법 - Google Patents
(1h-테트라졸-5-일)-2(1h)-퀴놀리논, 나프티리디논 및 그의 제조방법Info
- Publication number
- KR840008153A KR840008153A KR1019840001514A KR840001514A KR840008153A KR 840008153 A KR840008153 A KR 840008153A KR 1019840001514 A KR1019840001514 A KR 1019840001514A KR 840001514 A KR840001514 A KR 840001514A KR 840008153 A KR840008153 A KR 840008153A
- Authority
- KR
- South Korea
- Prior art keywords
- quinolinone
- tetrazol
- naphthyridinone
- preparation
- cyano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Laminated Bodies (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US478965 | 1983-03-25 | ||
| US06/478,965 US4735948A (en) | 1983-03-25 | 1983-03-25 | (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR840008153A true KR840008153A (ko) | 1984-12-13 |
| KR900003650B1 KR900003650B1 (ko) | 1990-05-28 |
Family
ID=23902120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019840001514A KR900003650B1 (ko) | 1983-03-25 | 1984-03-24 | (1h-테트라졸-5-일)-2(1h)-퀴놀리논, 나프티리디논 및 그의 제조방법 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4735948A (ko) |
| EP (1) | EP0120483B1 (ko) |
| JP (1) | JPS59176276A (ko) |
| KR (1) | KR900003650B1 (ko) |
| AT (1) | ATE26276T1 (ko) |
| AU (1) | AU562115B2 (ko) |
| CA (1) | CA1241001A (ko) |
| DE (1) | DE3462895D1 (ko) |
| DK (1) | DK163238C (ko) |
| ES (1) | ES8601963A1 (ko) |
| GR (1) | GR81908B (ko) |
| IE (1) | IE57073B1 (ko) |
| IL (1) | IL71319A (ko) |
| NO (1) | NO841157L (ko) |
| NZ (1) | NZ207581A (ko) |
| PT (1) | PT78289B (ko) |
| ZA (1) | ZA842065B (ko) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT79031B (en) * | 1983-08-20 | 1986-08-22 | Boots Co Plc | Therapeutic agents |
| US5358949A (en) * | 1986-03-05 | 1994-10-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives |
| US4916131A (en) * | 1986-10-15 | 1990-04-10 | Schering Corporation | Naphthyridine derivatives and method for treating allergic reactions |
| EP0267691A3 (en) * | 1986-10-15 | 1989-08-23 | Schering Corporation | Use of 1-substituted naphthyridine and pyridopyrazine derivatives for the preparation of medicaments with immunosuppressor activity. |
| US5037826A (en) * | 1986-10-15 | 1991-08-06 | Schering Corporation | 1-substituted naphthyridine and pyridopyrazine derivatives |
| US5064837A (en) * | 1989-11-13 | 1991-11-12 | Schering Corporation | 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions |
| GB9026389D0 (en) * | 1990-12-05 | 1991-01-23 | Merck Sharp & Dohme | Therapeutic agents |
| GB9125485D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
| WO1994012499A1 (en) * | 1992-12-01 | 1994-06-09 | The Green Cross Corporation | 1,8-naphthyridin-2-one derivative and use thereof_ |
| DE19727410A1 (de) * | 1997-06-27 | 1999-01-07 | Hoechst Schering Agrevo Gmbh | 3-(5-Tetrazolylcarbonyl)-2-chinolone und diese enthaltende nutzpflanzenschützende Mittel |
| GB0316546D0 (en) | 2003-07-15 | 2003-08-20 | Novartis Ag | Process for the manufacture of organic compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1444369A (en) * | 1973-04-05 | 1976-07-28 | Allen & Hanburys Ltd | 1,8-naphthyridines |
| US3993656A (en) * | 1974-11-19 | 1976-11-23 | Merck & Co., Inc. | 1,8-Naphthyridine compounds |
| US4035368A (en) * | 1975-04-02 | 1977-07-12 | Riker Laboratories, Inc. | Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds |
| US4350817A (en) * | 1980-02-28 | 1982-09-21 | American Home Products Corporation | 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives |
| ES8608874A1 (es) * | 1984-05-29 | 1986-09-01 | Pfizer | Un procedimiento para la preparacion de una 2-(1h)-quinolona |
-
1983
- 1983-03-25 US US06/478,965 patent/US4735948A/en not_active Expired - Lifetime
-
1984
- 1984-03-20 CA CA000449959A patent/CA1241001A/en not_active Expired
- 1984-03-20 ZA ZA842065A patent/ZA842065B/xx unknown
- 1984-03-21 NZ NZ207581A patent/NZ207581A/en unknown
- 1984-03-21 GR GR74164A patent/GR81908B/el unknown
- 1984-03-21 PT PT78289A patent/PT78289B/pt not_active IP Right Cessation
- 1984-03-21 AU AU25952/84A patent/AU562115B2/en not_active Ceased
- 1984-03-22 ES ES530877A patent/ES8601963A1/es not_active Expired
- 1984-03-22 IL IL71319A patent/IL71319A/xx unknown
- 1984-03-22 JP JP59053691A patent/JPS59176276A/ja active Granted
- 1984-03-23 DE DE8484103231T patent/DE3462895D1/de not_active Expired
- 1984-03-23 IE IE720/84A patent/IE57073B1/en not_active IP Right Cessation
- 1984-03-23 DK DK165684A patent/DK163238C/da not_active IP Right Cessation
- 1984-03-23 EP EP84103231A patent/EP0120483B1/en not_active Expired
- 1984-03-23 NO NO841157A patent/NO841157L/no unknown
- 1984-03-23 AT AT84103231T patent/ATE26276T1/de active
- 1984-03-24 KR KR1019840001514A patent/KR900003650B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES530877A0 (es) | 1985-11-01 |
| EP0120483A1 (en) | 1984-10-03 |
| NO841157L (no) | 1984-09-26 |
| IE57073B1 (en) | 1992-04-22 |
| NZ207581A (en) | 1987-01-23 |
| PT78289B (en) | 1986-04-22 |
| PT78289A (en) | 1984-04-01 |
| EP0120483B1 (en) | 1987-04-01 |
| DK165684D0 (da) | 1984-03-23 |
| ATE26276T1 (de) | 1987-04-15 |
| DE3462895D1 (de) | 1987-05-07 |
| AU2595284A (en) | 1984-09-27 |
| GR81908B (ko) | 1984-12-12 |
| ES8601963A1 (es) | 1985-11-01 |
| JPS59176276A (ja) | 1984-10-05 |
| IL71319A (en) | 1988-03-31 |
| AU562115B2 (en) | 1987-05-28 |
| DK163238C (da) | 1992-06-29 |
| ZA842065B (en) | 1984-10-31 |
| DK163238B (da) | 1992-02-10 |
| IL71319A0 (en) | 1984-06-29 |
| US4735948A (en) | 1988-04-05 |
| KR900003650B1 (ko) | 1990-05-28 |
| DK165684A (da) | 1984-09-26 |
| JPH0452273B2 (ko) | 1992-08-21 |
| IE840720L (en) | 1984-09-25 |
| CA1241001A (en) | 1988-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1199243B (it) | Composti eterociclici,loro preparazione e loro impiego come medicamenti | |
| IT8004812A0 (it) | Procedimento per la riduzione di emissione di nox. | |
| DZ629A1 (fr) | Dérivés de la furo-(3,4-c)-pyridine ainsi que leurpréparation. | |
| KR840008153A (ko) | (1h-테트라졸-5-일)-2(1h)-퀴놀리논, 나프티리디논 및 그의 제조방법 | |
| IT1207498B (it) | Procedimento per la preparazione di composizioni plasto-elastomeriche poliolefiniche, mediante vulcanizzazione dinamica. | |
| IE831145L (en) | Pyridine derivatives | |
| DE3577087D1 (de) | Durch tertiaeres alkyl monosubstituiertes toluylendiamin und derivate. | |
| ATE27599T1 (de) | Rooperol und dessen derivate. | |
| NO841156L (no) | Fremgangsmaate ved fremstilling av nye (1h-tetrazol-5-yl)-tetrazolo (1,5-a)-kinoliner | |
| IT1199237B (it) | Composti bisazoici,loro preparazione e loro impiego come coloranti | |
| SE8400118D0 (sv) | Substituted carboxy-thiazolo(3,2-a)pyrimidine derivatives and process for their preparation | |
| DE3568432D1 (de) | Tetrazolothienopyridines | |
| IT8324354A0 (it) | Procedimento per eliminare le infiltrazioni di aria esterna attraverso aperture quali portoni, in particolare per edifici industriali. | |
| FI864887A0 (fi) | Foerfarande foer framstaellning av 1-metyl-1,4-androstadien-3,17-dion. | |
| NL7802522A (nl) | Nieuwe 1-fenyl-2-amino-1,3-propaandiol-n-alkyl- derivaten en werkwijze voor de bereiding daar- van. | |
| ES517874A0 (es) | Procedimiento de preparacion de derivados de diaza-3,7a-cicloherta-(j,k)-fluorenos. | |
| DE3576076D1 (de) | (tetrazolyl)thienopyridone. | |
| ATE54544T1 (de) | Natriumarmes, als kochsalzsubstitut geeignetes salzgemisch. | |
| ATE23332T1 (de) | Alpha-phenyl-2-(aza)benzothiazolythioglykolsaeur n und deren derivate. | |
| ATE38030T1 (de) | N-substituierte butyramide derivate. | |
| IT8024997A0 (it) | Procedimento per la preparazione di oggetti di polivinilcloruro duro cellulare. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| G160 | Decision to publish patent application | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 19930325 Year of fee payment: 4 |
|
| LAPS | Lapse due to unpaid annual fee |